Ophthalmic Sutures Market (By Type: Natural, Synthetic; By Absorption Capacity: Absorbable, Non-absorbable; By Application: Corneal Transplantation Surgery, Cataract Surgery, Vitrectomy Surgery, Iridectomy Surgery, Oculoplastic Surgery, Others; By End-use: Hospitals, Ambulatory Surgical Centers, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Ophthalmic Sutures Market
5.1. COVID-19 Landscape: Ophthalmic Sutures Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Ophthalmic Sutures Market, By Type
8.1. Ophthalmic Sutures Market Revenue and Volume Forecast, by Type, 2024-2033
8.1.1. Natural
8.1.1.1. Market Revenue and Volume Forecast (2021-2033)
8.1.2. Synthetic
8.1.2.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 9. Global Ophthalmic Sutures Market, By Absorption Capacity
9.1. Ophthalmic Sutures Market Revenue and Volume Forecast, by Absorption Capacity, 2024-2033
9.1.1. Absorbable
9.1.1.1. Market Revenue and Volume Forecast (2021-2033)
9.1.2. Non-absorbable
9.1.2.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 10. Global Ophthalmic Sutures Market, By Application
10.1. Ophthalmic Sutures Market Revenue and Volume Forecast, by Application, 2024-2033
10.1.1. Corneal Transplantation Surgery
10.1.1.1. Market Revenue and Volume Forecast (2021-2033)
10.1.2. Cataract Surgery
10.1.2.1. Market Revenue and Volume Forecast (2021-2033)
10.1.3. Vitrectomy Surgery
10.1.3.1. Market Revenue and Volume Forecast (2021-2033)
10.1.4. Iridectomy Surgery
10.1.4.1. Market Revenue and Volume Forecast (2021-2033)
10.1.5. Oculoplastic Surgery
10.1.5.1. Market Revenue and Volume Forecast (2021-2033)
10.1.6. Others
10.1.6.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 11. Global Ophthalmic Sutures Market, By End-use
11.1. Ophthalmic Sutures Market Revenue and Volume Forecast, by End-use, 2024-2033
11.1.1. Hospitals
11.1.1.1. Market Revenue and Volume Forecast (2021-2033)
11.1.2. Ambulatory Surgical Centers
11.1.2.1. Market Revenue and Volume Forecast (2021-2033)
11.1.3. Others
11.1.3.1. Market Revenue and Volume Forecast (2021-2033)
Chapter 12. Global Ophthalmic Sutures Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.1.2. Market Revenue and Volume Forecast, by Absorption Capacity (2021-2033)
12.1.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.1.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.1.5. U.S.
12.1.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.1.5.2. Market Revenue and Volume Forecast, by Absorption Capacity (2021-2033)
12.1.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.1.5.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.1.6.2. Market Revenue and Volume Forecast, by Absorption Capacity (2021-2033)
12.1.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.1.6.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.2. Europe
12.2.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.2.2. Market Revenue and Volume Forecast, by Absorption Capacity (2021-2033)
12.2.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.2.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.2.5. UK
12.2.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.2.5.2. Market Revenue and Volume Forecast, by Absorption Capacity (2021-2033)
12.2.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.2.5.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.2.6. Germany
12.2.6.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.2.6.2. Market Revenue and Volume Forecast, by Absorption Capacity (2021-2033)
12.2.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.2.6.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.2.7. France
12.2.7.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.2.7.2. Market Revenue and Volume Forecast, by Absorption Capacity (2021-2033)
12.2.7.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.2.7.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.2.8.2. Market Revenue and Volume Forecast, by Absorption Capacity (2021-2033)
12.2.8.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.2.8.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.3. APAC
12.3.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.3.2. Market Revenue and Volume Forecast, by Absorption Capacity (2021-2033)
12.3.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.3.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.3.5. India
12.3.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.3.5.2. Market Revenue and Volume Forecast, by Absorption Capacity (2021-2033)
12.3.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.3.5.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.3.6. China
12.3.6.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.3.6.2. Market Revenue and Volume Forecast, by Absorption Capacity (2021-2033)
12.3.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.3.6.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.3.7. Japan
12.3.7.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.3.7.2. Market Revenue and Volume Forecast, by Absorption Capacity (2021-2033)
12.3.7.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.3.7.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.3.8.2. Market Revenue and Volume Forecast, by Absorption Capacity (2021-2033)
12.3.8.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.3.8.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.4. MEA
12.4.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.4.2. Market Revenue and Volume Forecast, by Absorption Capacity (2021-2033)
12.4.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.4.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.4.5. GCC
12.4.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.4.5.2. Market Revenue and Volume Forecast, by Absorption Capacity (2021-2033)
12.4.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.4.5.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.4.6. North Africa
12.4.6.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.4.6.2. Market Revenue and Volume Forecast, by Absorption Capacity (2021-2033)
12.4.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.4.6.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.4.7. South Africa
12.4.7.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.4.7.2. Market Revenue and Volume Forecast, by Absorption Capacity (2021-2033)
12.4.7.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.4.7.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.4.8.2. Market Revenue and Volume Forecast, by Absorption Capacity (2021-2033)
12.4.8.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.4.8.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.5. Latin America
12.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.5.2. Market Revenue and Volume Forecast, by Absorption Capacity (2021-2033)
12.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.5.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.5.5. Brazil
12.5.5.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.5.5.2. Market Revenue and Volume Forecast, by Absorption Capacity (2021-2033)
12.5.5.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.5.5.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Volume Forecast, by Type (2021-2033)
12.5.6.2. Market Revenue and Volume Forecast, by Absorption Capacity (2021-2033)
12.5.6.3. Market Revenue and Volume Forecast, by Application (2021-2033)
12.5.6.4. Market Revenue and Volume Forecast, by End-use (2021-2033)
Chapter 13. Company Profiles
13.1. Accutome Inc.
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Asset Medical Sarl
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Alcon Inc.
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Aurolab
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. FCI Ophthalmic Inc.
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. Medtronic Plc
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. Rumex International Co.
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Surgical Specialties Corp
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Teleflex Incorporated
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Unilever
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client